Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favipiravir for children with Ebola.
Bouazza N, Treluyer JM, Foissac F, Mentré F, Taburet AM, Guedj J, Anglaret X, de Lamballerie X, Keïta S, Malvy D, Frange P. Bouazza N, et al. Among authors: malvy d. Lancet. 2015 Feb 14;385(9968):603-604. doi: 10.1016/S0140-6736(15)60232-X. Lancet. 2015. PMID: 25706078 No abstract available.
No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.
Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P. Lachâtre M, et al. Among authors: malvy d. Clin Microbiol Infect. 2018 Mar;24(3):310-311. doi: 10.1016/j.cmi.2017.09.004. Epub 2017 Sep 9. Clin Microbiol Infect. 2018. PMID: 28899839 Free article. No abstract available.
Dose regimen of favipiravir for Ebola virus disease.
Mentré F, Taburet AM, Guedj J, Anglaret X, Keïta S, de Lamballerie X, Malvy D. Mentré F, et al. Among authors: malvy d. Lancet Infect Dis. 2015 Feb;15(2):150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28. Lancet Infect Dis. 2015. PMID: 25435054 No abstract available.
Individual and contextual risk factors for chikungunya virus infection: the SEROCHIK cross-sectional population-based study.
Fred A, Fianu A, Béral M, Guernier V, Sissoko D, Méchain M, Michault A, Boisson V, Gaüzère BA, Favier F, Malvy D, Gérardin P; SEROCHIK group. Fred A, et al. Among authors: malvy d. Epidemiol Infect. 2018 Jun;146(8):1056-1064. doi: 10.1017/S0950268818000341. Epub 2018 May 3. Epidemiol Infect. 2018. PMID: 29720285 Free PMC article.
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
PREVAIL II Writing Group; Multi-National PREVAIL II Study Team; Davey RT Jr, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D. PREVAIL II Writing Group, et al. Among authors: malvy d. N Engl J Med. 2016 Oct 13;375(15):1448-1456. doi: 10.1056/NEJMoa1604330. N Engl J Med. 2016. PMID: 27732819 Free PMC article. Clinical Trial.
521 results